Melanoma dedifferentiation induced by IFN-? epigenetic remodeling in response to anti-PD-1 therapy (2021)
Attributed to:
Enhancing immunogenicity in non-viral low mutation burden tumours
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1172/jci145859
PubMed Identifier: 33914706
Publication URI: http://europepmc.org/abstract/MED/33914706
Type: Journal Article/Review
Parent Publication: Journal of Clinical Investigation
Issue: 12
ISSN: 0021-9738